Other CRE Guidelines and Resources

Guidelines, publications, and other CRE resources for Health Professionals.

Infection Prevention and Control Guidelines

CRE Guidelines and Recommendations

Publications

  1. Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies ICHE. 2008;29:1099-1106. Gopi Patel, Shirish Huprikar, Stephanie H. Factor, et al. http://www.journals.uchicago.edu/toc/iche/current
  2. Risk Factors and Clinical Impact of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae ICHE. 2009;30:1180-1185. Leanne B. Gasnik, Paul H. Edelstein, Ebbing Lautenbach, et al.http://www.journals.uchicago.edu/toc/iche/current
  3. Success of an Infection Control Program to Reduce the Spread of Carbapenem-Resistant Klebsiella pneumoniae ICHE. 2009;30:447-452. Sandeep Kochar, Timothy Sheard, Roopali Sharma, et al. http://www.journals.uchicago.edu/toc/iche/current
  4. Successful Control of an Outbreak of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae at a Long-Term Acute Care Hospital ICHE. 2010;31:341-347. L. Silvia Munoz-Price, Mary K. Hayden, Karen Lolans et al. http://www.journals.uchicago.edu/toc/iche/current
  5. Cluster of bloodstream infections caused by KPC-2 carbapenemase-producing Klebsiella pneumoniae in Manhattan. Am J Infect Control. 2009;37(2):121-6. A.S. Nadkarni, T. Schliep, L. Khan, C.B. Zeana. http://www.ajicjournal.org/
  6. Characterization of a New Metallo-β-Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India. Antimicrobial Agents and Chemotherapy. 2009;53(12):5046-5054. D. Yong, M.A. Toleman, C.G. Giske, et al.

Updated Tuesday, 17-Jan-2012 14:41:56 CST